| Item Type | Name |
|
Concept
|
Bone Marrow Cells
|
|
Concept
|
B-Lymphocytes
|
|
Concept
|
Dendritic Cells
|
|
Concept
|
Gene Expression Regulation
|
|
Concept
|
Hematopoietic Stem Cells
|
|
Concept
|
HeLa Cells
|
|
Concept
|
Tissue Banks
|
|
Concept
|
Tissue Donors
|
|
Concept
|
Stem Cells
|
|
Concept
|
Tumor Cells, Cultured
|
|
Concept
|
CD4-Positive T-Lymphocytes
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Epitopes, T-Lymphocyte
|
|
Concept
|
Jurkat Cells
|
|
Concept
|
Peripheral Blood Stem Cell Transplantation
|
|
Concept
|
Granulocyte Precursor Cells
|
|
Concept
|
Adult Stem Cells
|
|
Concept
|
HEK293 Cells
|
|
Concept
|
Down-Regulation
|
|
Concept
|
Leukemia, Prolymphocytic, T-Cell
|
|
Concept
|
Erythroid Precursor Cells
|
|
Concept
|
Endothelial Cells
|
|
Concept
|
Cells, Cultured
|
|
Concept
|
Lymphocytes
|
|
Concept
|
Receptors, Antigen, T-Cell
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Lymphoma, T-Cell, Peripheral
|
|
Concept
|
Myeloid Cells
|
|
Academic Article
|
Regulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathway.
|
|
Academic Article
|
Cutting edge: activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia.
|
|
Academic Article
|
Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.
|
|
Academic Article
|
Order of patient entry influences outcome for metastatic renal cell cancer after non-myeloablative allogeneic stem cell transplantation.
|
|
Academic Article
|
Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts.
|
|
Academic Article
|
Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma.
|
|
Academic Article
|
Irreversible myelosuppression after fludarabine-melphalan conditioning: observations in patients with graft rejection.
|
|
Academic Article
|
The next frontier for stem cell transplantation: finding a donor for all.
|
|
Academic Article
|
Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease.
|
|
Academic Article
|
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.
|
|
Academic Article
|
Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant.
|
|
Academic Article
|
Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.
|
|
Academic Article
|
Distinct functions of erythropoietin and stem cell factor are linked to activation of mTOR kinase signaling pathway in human erythroid progenitors.
|
|
Academic Article
|
T-cell-depleted reduced-intensity conditioning transplantation for lymphoma: do donor lymphocyte infusions really matter?
|
|
Academic Article
|
Epidemiology of vancomycin-resistant enterococci among patients on an adult stem cell transplant unit: observations from an active surveillance program.
|
|
Academic Article
|
Low incidence of CMV viremia and disease after allogeneic peripheral blood stem cell transplantation. Role of pretransplant ganciclovir and post-transplant acyclovir.
|
|
Academic Article
|
Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options.
|
|
Academic Article
|
Older age but not donor health impairs allogeneic granulocyte colony-stimulating factor (G-CSF) peripheral blood stem cell mobilization.
|
|
Academic Article
|
T-cell-depleted allogeneic transplant without donor leukocyte infusions results in excellent long-term survival in patients with multiply relapsed Lymphoma. Predictors for survival after transplant relapse.
|
|
Academic Article
|
Influence of related donor age on outcomes after peripheral blood stem cell transplantation.
|
|
Academic Article
|
Immune reconstitution after combined haploidentical and umbilical cord blood transplant.
|
|
Academic Article
|
Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications.
|
|
Academic Article
|
Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma.
|
|
Academic Article
|
Interdigitating dendritic cell tumors in two patients exposed to topical calcineurin inhibitors.
|
|
Academic Article
|
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas.
|
|
Academic Article
|
Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
|
|
Academic Article
|
Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
|
|
Academic Article
|
Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.
|
|
Academic Article
|
Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow.
|
|
Academic Article
|
Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes.
|
|
Academic Article
|
Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis.
|
|
Academic Article
|
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
|
|
Academic Article
|
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
|
|
Academic Article
|
Addition of plerixafor to mobilization regimens in autologous peripheral blood stem cell transplants does not affect the correlation of preharvest hematopoietic precursor cell enumeration with first-harvest CD34+ stem cell yield.
|
|
Academic Article
|
Characterization of human hematopoietic stem cells.
|
|
Academic Article
|
Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro.
|
|
Academic Article
|
Advances in umbilical cord blood transplant: a summary of the 11th International Cord Blood Symposium, San Francisco, 6-8 June 2013.
|
|
Academic Article
|
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect.
|
|
Academic Article
|
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
|
|
Academic Article
|
Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion.
|
|
Academic Article
|
To the end of chronic lymphocytic leukemia: what should be the role of allogeneic transplant?
|
|
Academic Article
|
Stem cell transplantation for indolent lymphoma: a reappraisal.
|
|
Academic Article
|
Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.
|
|
Academic Article
|
Allogeneic transplant for peripheral T-cell lymphoma: a sparkle of hope and many questions.
|
|
Academic Article
|
The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
|
|
Academic Article
|
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
|
|
Academic Article
|
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.
|
|
Academic Article
|
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation.
|
|
Academic Article
|
Acquired cyclic amegakaryocytic thrombocytopenia associated with an immunoglobulin blocking the action of granulocyte-macrophage colony-stimulating factor.
|
|
Academic Article
|
Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer.
|
|
Academic Article
|
Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts.
|
|
Academic Article
|
Reduced-intensity and nonmyeloablative conditioning regimens.
|
|
Academic Article
|
Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
|
|
Academic Article
|
Peripheral-blood versus bone marrow stem cells.
|
|
Academic Article
|
Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation.
|
|
Academic Article
|
Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors.
|
|
Academic Article
|
Statement of Retraction: Huang H, Wu D, Fu J, Chen G. "multiple myeloma cells undergo differentiation upon exposure to rosiglitazone and all-trans retinoic acid".
|
|
Academic Article
|
How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusions.
|
|
Academic Article
|
Topping it up: methods to improve cord blood transplantation outcomes by increasing the number of CD34+ cells.
|
|
Academic Article
|
A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration.
|
|
Academic Article
|
Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.
|
|
Academic Article
|
Engraftment for CD34 selected stem cell products is not compromised by cryopreservation.
|
|
Academic Article
|
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
|
|
Academic Article
|
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
|
|
Academic Article
|
Haplo-cord transplant: HLA-matching determines graft dominance.
|
|
Academic Article
|
Cord blood chimerism and relapse after haplo-cord transplantation.
|
|
Academic Article
|
Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplant.
|
|
Academic Article
|
Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors.
|
|
Academic Article
|
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results.
|
|
Academic Article
|
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results.
|
|
Academic Article
|
Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices.
|
|
Academic Article
|
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
|
|
Academic Article
|
Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience.
|
|
Academic Article
|
Comparison of time to engraftment between autologous patients receiving washed versus non-washed cryopreserved peripheral blood stem cell products.
|
|
Academic Article
|
Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation.
|
|
Academic Article
|
Donor graft genotypes versus leukemia.
|
|
Academic Article
|
Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL.
|
|
Academic Article
|
Alternative Donor Transplantation for Lymphoid Malignancies: How Far We Have Come.
|
|
Academic Article
|
Cord blood transplants supported by unrelated donor CD34+ progenitor cells.
|
|
Academic Article
|
Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy.
|
|
Academic Article
|
MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab.
|
|
Academic Article
|
Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes.
|
|
Academic Article
|
Now you see me, now you don't: Isolated central nervous system recurrence of CD19-negative diffuse large B-cell lymphoma following CD19-directed CAR T-cell treatment.
|
|
Academic Article
|
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation.
|
|
Grant
|
Busulfan conditioning: optimization, kinetics, genomics
|
|
Grant
|
Minor Histocompatilibity Vaccination After Allo-Transpl*
|
|
Grant
|
TCR-gene modified t-cells for adaptive immunotherapy
|
|
Grant
|
CAR T Cells for Advanced Thyroid Cancer
|
|
Academic Article
|
Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia.
|
|
Academic Article
|
XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.
|